Target intelligence / Profile preview

Influenza A internal proteins

Molecular classification
Enzyme, Structural protein, Ion channel, Regulatory/non-structural
01

Overview

Influenza A "internal proteins" refers collectively to the set of proteins encoded by segments of the influenza A viral genome that are located inside the virion, distinct from the surface glycoproteins hemagglutinin (HA) and neuraminidase (NA). This includes the polymerase complex—polymerase basic protein 2 (PB2), polymerase basic protein 1 (PB1), and polymerase acidic protein (PA)—responsible for viral RNA transcription and replication; the nucleoprotein (NP), which encapsidates viral RNA; the matrix protein 1 (M1), which forms a structural layer inside the viral envelope; the matrix protein 2 (M2), a proton channel important for viral uncoating; and nonstructural proteins including NS1 (which antagonizes the host interferon response) and NEP/NS2 (involved in viral ribonucleoprotein export). These proteins are essential for the replication, assembly, and pathogenicity of influenza A, and several individual internal proteins are targets for antiviral drug development.

02

Mechanism of action

M2 ion channel blockade prevents viral uncoating by stopping acidification required for viral RNP release into host cytoplasm. (Potential, under investigation): Inhibitors of viral polymerase–protein–protein interactions, such as PB1–PB2 complex, but these are not yet clinically approved.

03

Biological functions

Viral genome replication and transcriptionEncapsidation of viral RNAVirion assembly and buddingIon transport and acidificationRegulation of host immune response and viral RNP export
04

Disease associations

Infection
05

Safety considerations

Drug resistance is a major issue for M2 inhibitors; nearly all circulating human influenza A viruses are now resistant to amantadine and rimantadine
06

Interacting drugs

Amantadine and rimantadine

Beyond the preview

Go deeper on Influenza A internal proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza A internal proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call